Portal de Periódicos da CAPES

Pathogenesis and Outcome of Biliary Atresia: Current Concepts

2003; Lippincott Williams & Wilkins; Volume: 37; Issue: 1 Linguagem: Inglês

10.1002/j.1536-4801.2003.tb08098.x

1536-4801

Ronald J. Sokol, Cara L. Mack, Michael R. Narkewicz, Frederick M. Karrer,

Congenital Anomalies and Fetal Surgery

Journal of Pediatric Gastroenterology and NutritionVolume 37, Issue 1 p. 4-21 Invited Review Pathogenesis and Outcome of Biliary Atresia: Current Concepts Ronald J. Sokol, Corresponding Author Ronald J. Sokol [email protected] Pediatric Liver Center and Liver Transplantation Program, Section of Pediatric Gastroenterology, Hepatology and Nutrition, The Children's Hospital, Denver, Colorado, U.S.A. Department of Pediatrics, The Children's Hospital, Denver, Colorado, U.S.A. the Pediatric General Clinical Research Center, University of Colorado Health Sciences Center, The Children's Hospital, Denver, Colorado, U.S.A.Address correspondence and reprint requests to Dr. Ronald J. Sokol, Professor and Vice Chair of Pediatrics, Box B290, The Children's Hospital, 1056 East 19th Avenue, Denver, Colorado 80218, U.S.A. (e-mail: [email protected]).Search for more papers by this authorCara Mack, Cara Mack Pediatric Liver Center and Liver Transplantation Program, Section of Pediatric Gastroenterology, Hepatology and Nutrition, The Children's Hospital, Denver, Colorado, U.S.A. Department of Pediatrics, The Children's Hospital, Denver, Colorado, U.S.A.Search for more papers by this authorMichael R. Narkewicz, Michael R. Narkewicz Pediatric Liver Center and Liver Transplantation Program, Section of Pediatric Gastroenterology, Hepatology and Nutrition, The Children's Hospital, Denver, Colorado, U.S.A. Department of Pediatrics, The Children's Hospital, Denver, Colorado, U.S.A.Search for more papers by this authorFrederick M. Karrer, Frederick M. Karrer Pediatric Liver Center and Liver Transplantation Program, Section of Pediatric Gastroenterology, Hepatology and Nutrition, The Children's Hospital, Denver, Colorado, U.S.A. Department of Surgery, The Children's Hospital, Denver, Colorado, U.S.A.Search for more papers by this author Ronald J. Sokol, Corresponding Author Ronald J. Sokol [email protected] Pediatric Liver Center and Liver Transplantation Program, Section of Pediatric Gastroenterology, Hepatology and Nutrition, The Children's Hospital, Denver, Colorado, U.S.A. Department of Pediatrics, The Children's Hospital, Denver, Colorado, U.S.A. the Pediatric General Clinical Research Center, University of Colorado Health Sciences Center, The Children's Hospital, Denver, Colorado, U.S.A.Address correspondence and reprint requests to Dr. Ronald J. Sokol, Professor and Vice Chair of Pediatrics, Box B290, The Children's Hospital, 1056 East 19th Avenue, Denver, Colorado 80218, U.S.A. (e-mail: [email protected]).Search for more papers by this authorCara Mack, Cara Mack Pediatric Liver Center and Liver Transplantation Program, Section of Pediatric Gastroenterology, Hepatology and Nutrition, The Children's Hospital, Denver, Colorado, U.S.A. Department of Pediatrics, The Children's Hospital, Denver, Colorado, U.S.A.Search for more papers by this authorMichael R. Narkewicz, Michael R. Narkewicz Pediatric Liver Center and Liver Transplantation Program, Section of Pediatric Gastroenterology, Hepatology and Nutrition, The Children's Hospital, Denver, Colorado, U.S.A. Department of Pediatrics, The Children's Hospital, Denver, Colorado, U.S.A.Search for more papers by this authorFrederick M. Karrer, Frederick M. Karrer Pediatric Liver Center and Liver Transplantation Program, Section of Pediatric Gastroenterology, Hepatology and Nutrition, The Children's Hospital, Denver, Colorado, U.S.A. Department of Surgery, The Children's Hospital, Denver, Colorado, U.S.A.Search for more papers by this author First published: 01 July 2003 https://doi.org/10.1002/j.1536-4801.2003.tb08098.xCitations: 45 Supported in part by NIH grants 5 MO1 RR00069, General Clinical Research Centers Program, National Center for Research Resources; P30 DK34914; RO1 DK38446; UO1 DK62453; K08 DK060710; The Madigan Foundation; and the Abby Bennett Liver Research Fund. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1Balistreri WF, Grand R, Hoofnagle JH, et al. Biliary atresia: current concepts and research directions. Summary of a symposium. Hepatology 1996; 23: 1682–92. 10.1002/hep.510230652 CASPubMedWeb of Science®Google Scholar 2Bucuvalas JC, Ryckman FC, Atherton H, et al. Predictors of cost of liver transplantation in children: a single center study. J Pediatr 2001; 139: 66–74. 10.1067/mpd.2001.115068 CASPubMedWeb of Science®Google Scholar 3Yoon PW, Bresee JS, Olney RS, et al. Epidemiology of biliary atresia: a population-based study. Pediatrics 1997; 99: 376–82. 10.1542/peds.99.3.376 CASPubMedWeb of Science®Google Scholar 4Fischler B, Haglund B, Hjern A. A population-based study on the incidence and possible pre- and perinatal etiologic risk factors of biliary atresia. J Pediatr 2002; 141: 217–22. 10.1067/mpd.2002.126001 PubMedWeb of Science®Google Scholar 5Sokol RJ, Mack C. Etiopathogenesis of biliary atresia. Semin Liver Dis 2001; 21: 517–24. 10.1055/s-2001-19032 CASPubMedWeb of Science®Google Scholar 6Ohi R. Biliary atresia. A surgical perspective. Clin Liver Dis 2000; 4: 779–804. 10.1016/S1089-3261(05)70141-0 CASPubMedGoogle Scholar 7Davenport M, Savage M, Mowat AP, et al. Biliary atresia splenic malformation syndrome: an etiologic and prognostic subgroup. Surgery 1993; 113: 662–8. CASPubMedWeb of Science®Google Scholar 8Karrer FM, Hall RJ, Lilly JR. Biliary atresia and the polysplenia syndrome. J Pediatr Surg 1991; 26: 524–7. 10.1016/0022-3468(91)90697-R CASPubMedWeb of Science®Google Scholar 9Desmet V. The cholangiopathies. In: FJ Suchy, ed. Liver Disease in Children. Philadelphia: Lippincott, Williams & Wilkins; 2001: 39–62. Google Scholar 10Schweizer P. Treatment of extrahepatic biliary atresia: results and long-term prognosis after hepatic portoenterostomy. Pediatr Surg 1986; 1: 30–6. 10.1007/BF00171779 Google Scholar 11Mazziotti MV, Willis LK, Heuckeroth RO, et al. Anomalous development of the hepatobiliary system in the Inv mouse. Hepatology 1999; 30: 372–8. 10.1002/hep.510300223 CASPubMedWeb of Science®Google Scholar 12Desmet VJ. Congenital diseases of intrahepatic bile ducts: variations on the theme “ductal plate malformation.” Hepatology 1992; 16: 1069–83. 10.1002/hep.1840160434 CASPubMedWeb of Science®Google Scholar 13Balistreri WF. Liver disease in infancy and childhood. In: ER Schiff, MF Sorrell, WC Maddrey, eds. Schiff's Diseases of the Liver. Philadelphia: Lippincott-Raven Publishers; 1999: 1357–512. Google Scholar 14Setchell K, O'Connell N. Disorders of bile acid synthesis and metabolism: a metabolic basis for liver disease. In: FJ Suchy, RJ Sokol, WF Balistreri, eds. Liver Disease in Children. Philadelphia: Lippincott, Williams & Wilkins; 2001: 701–34. Google Scholar 15Tazawa Y, Kobayashi K, Ohura T, et al. Infantile cholestatic jaundice associated with adult-onset type II citrullinemia. J Pediatr 2001; 138: 735–40. 10.1067/mpd.2001.113264 CASPubMedWeb of Science®Google Scholar 16Sokol RJ, Stall C. Anthropometric evaluation of children with chronic liver disease. Am J Clin Nutr 1990; 52: 203–8. 10.1093/ajcn/52.2.203 CASPubMedWeb of Science®Google Scholar 17Suchy FJ. Approach to the infant with cholestasis. In: FJ Suchy, RJ Sokol, WF Balistreri, eds. Liver Disease in Children. Philadelphia: Lippincott, Williams & Wilkins; 2001: 187–94. Google Scholar 18Fung KP, Lau SP. Differentiation between extrahepatic and intrahepatic cholestasis by discriminant analysis. J Paediatr Child Health 1990; 26: 132–5. 10.1111/j.1440-1754.1990.tb02409.x CASPubMedWeb of Science®Google Scholar 19Feranchak A, Ramirez R, Sokol RJ. Medical and nutritional management of cholestasis. In: FJ Suchy, RJ Sokol, WF Balistreri, eds. Liver Disease in Children. Philadelphia: Lippincott, Williams & Wilkins; 2001: 195–238. Google Scholar 20Jacquemin E. Progressive familial intrahepatic cholestasis. Genetic basis and treatment. Clin Liver Dis 2000; 4: 753–63. 10.1016/S1089-3261(05)70139-2 CASPubMedGoogle Scholar 21Jacquemin E, Cresteil D, Manouvrier S, et al. Heterozygous nonsense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy. Lancet 1999; 353: 210–11. 10.1016/S0140-6736(05)77221-4 CASPubMedWeb of Science®Google Scholar 22Jacquemin E, De Vree JM, Cresteil D, et al. The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood. Gastroenterology 2001; 120: 1448–58. 10.1053/gast.2001.23984 CASPubMedWeb of Science®Google Scholar 23Colliton RP, Bason L, Lu FM, et al. Mutation analysis of Jagged1 (JAG1) in Alagille syndrome patients. Hum Mutat 2001; 17: 151–2. 10.1002/1098-1004(200102)17:2 3.0.CO;2-T CASPubMedWeb of Science®Google Scholar 24Schweizer P, Kerremans J. Discordant findings in extrahepatic bile duct atresia in 6 sets of twins. Z Kinderchir 1988; 43: 72–5. CASPubMedWeb of Science®Google Scholar 25Hyams JS, Glaser JH, Leichtner AM, et al. Discordance for biliary atresia in two sets of monozygotic twins. J Pediatr 1985; 107: 420–2. 10.1016/S0022-3476(85)80524-2 CASPubMedWeb of Science®Google Scholar 26Rolleston HD, Hayne LB. A case of congenital hepatic cirrhosis with obliterative cholangitis (congenital obliteration of the bile ducts). BMJ 1901; 1: 758–60. 10.1136/bmj.1.2100.758 CASPubMedGoogle Scholar 27Tan CE, Driver M, Howard ER, et al. Extrahepatic biliary atresia: a first-trimester event? Clues from light microscopy and immunohistochemistry. J Pediatr Surg 1994; 29: 808–14. 10.1016/0022-3468(94)90377-8 CASPubMedWeb of Science®Google Scholar 28Reynoso-Paz S, Coppel RL, Mackay IR, et al. The immunobiology of bile and biliary epithelium. Hepatology 1999; 30: 351–7. 10.1002/hep.510300218 CASPubMedWeb of Science®Google Scholar 29Yerushalmi B, Dahl R, Devereaux MW, et al. Bile acid-induced rat hepatocyte apoptosis is inhibited by antioxidants and blockers of the mitochondrial permeability transition. Hepatology 2001; 33: 616–26. 10.1053/jhep.2001.22702 CASPubMedWeb of Science®Google Scholar 30Friedman SL, Maher JJ, Bissell DM. Mechanisms and therapy of hepatic fibrosis: report of the AASLD Single Topic Basic Research Conference. Hepatology 2000; 32: 1403–8. 10.1053/jhep.2000.20243 CASPubMedGoogle Scholar 31Landing BH. Considerations of the pathogenesis of neonatal hepatitis, biliary atresia and choledochal cyst--the concept of infantile obstructive cholangiopathy. Prog Pediatr Surg 1974; 6: 113–39. CASPubMedGoogle Scholar 32Tarr PI, Haas JE, Christie DL. Biliary atresia, cytomegalovirus, and age at referral. Pediatrics 1996; 97(6 Pt 1): 828–31. 10.1542/peds.97.6.828 CASPubMedWeb of Science®Google Scholar 33Fischler B, Ehrnst A, Forsgren M, et al. The viral association of neonatal cholestasis in Sweden: a possible link between cytomegalovirus infection and extrahepatic biliary atresia. J Pediatr Gastroenterol Nutr 1998; 27: 57–64. 10.1097/00005176-199807000-00010 CASPubMedWeb of Science®Google Scholar 34Jevon GP, Dimmick JE. Biliary atresia and cytomegalovirus infection: a DNA study. Pediatr Dev Pathol 1999; 2: 11–4. 10.1007/s100249900083 CASPubMedWeb of Science®Google Scholar 35Bangaru B, Morecki R, Glaser JH, et al. Comparative studies of biliary atresia in the human newborn and reovirus-induced cholangitis in weanling mice. Lab Invest 1980; 43: 456–62. CASPubMedWeb of Science®Google Scholar 36Morecki R, Glaser JH, Cho S, et al. Biliary atresia and reovirus type 3 infection. N Engl J Med 1982; 307: 481–4. 10.1056/NEJM198208193070806 CASPubMedWeb of Science®Google Scholar 37Morecki R, Glaser JH, Johnson AB, et al. Detection of reovirus type 3 in the porta hepatis of an infant with extrahepatic biliary atresia: ultrastructural and immunocytochemical study. Hepatology 1984; 4: 1137–42. 10.1002/hep.1840040608 CASPubMedWeb of Science®Google Scholar 38Rosenberg DP, Morecki R, Lollini LO, et al. Extrahepatic biliary atresia in a rhesus monkey (Macaca mulatta). Hepatology 1983; 3: 577–80. 10.1002/hep.1840030417 CASPubMedWeb of Science®Google Scholar 39Brown WR, Sokol RJ, Levin MJ, et al. Lack of correlation between infection with reovirus 3 and extrahepatic biliary atresia or neonatal hepatitis. J Pediatr 1988; 113: 670–6. 10.1016/S0022-3476(88)80376-7 CASPubMedWeb of Science®Google Scholar 40Dussaix E, Hadchouel M, Tardieu M, et al. Biliary atresia and reovirus type 3 infection. N Engl J Med 1984; 310: 658. 10.1056/NEJM198403083101016 CASPubMedWeb of Science®Google Scholar 41Glaser JH, Balistreri WF, Morecki R. Role of reovirus type 3 in persistent infantile cholestasis. J Pediatr 1984; 105: 912–5. 10.1016/S0022-3476(84)80076-1 CASPubMedWeb of Science®Google Scholar 42Steele MI, Marshall CM, Lloyd RE, et al. Reovirus 3 not detected by reverse transcriptase-mediated polymerase chain reaction analysis of preserved tissue from infants with cholestatic liver disease. Hepatology 1995; 21: 697–702. 10.1002/hep.1840210315 CASPubMedWeb of Science®Google Scholar 43Tyler KL, Sokol RJ, Oberhaus SM, et al. Detection of reovirus RNA in hepatobiliary tissues from patients with extrahepatic biliary atresia and choledochal cysts. Hepatology 1998; 27: 1475–82. 10.1002/hep.510270603 CASPubMedWeb of Science®Google Scholar 44Riepenhoff-Talty M, Schaekel K, Clark HF, et al. Group A rotaviruses produce extrahepatic biliary obstruction in orally inoculated newborn mice. Pediatr Res 1993; 33(4 Pt 1): 394–9. CASPubMedWeb of Science®Google Scholar 45Czech-Schmidt G, Verhagen W, Szavay P, et al. Immunological gap in the infectious animal model for biliary atresia. J Surg Res 2001; 101: 62–7. 10.1006/jsre.2001.6234 CASPubMedWeb of Science®Google Scholar 46Petersen C, Bruns E, Kuske M, et al. Treatment of extrahepatic biliary atresia with interferon-alpha in a murine infectious model. Pediatr Res 1997; 42: 623–8. 10.1203/00006450-199711000-00013 CASPubMedWeb of Science®Google Scholar 47Qiao H, De Vincentes A, Alashari M, et al. Pathogenesis of rotavirus-induced bile duct obstruction (a model for human biliary atresia) in normal Balb/c and CB17 scid mice with severe combined immunodeficiency (SCID). Pediatr Res 1999; 45: 116A. 10.1203/00006450-199904020-00691 Web of Science®Google Scholar 48Riepenhoff-Talty M, Gouvea V, Evans MJ, et al. Detection of group C rotavirus in infants with extrahepatic biliary atresia. J Infect Dis 1996; 174: 8–15. 10.1093/infdis/174.1.8 CASPubMedWeb of Science®Google Scholar 49Bobo L, Ojeh C, Chiu D, et al. Lack of evidence for rotavirus by polymerase chain reaction/enzyme immunoassay of hepatobiliary samples from children with biliary atresia. Pediatr Res 1997; 41: 229–34. 10.1203/00006450-199702000-00013 CASPubMedWeb of Science®Google Scholar 50Drut R, Drut RM, Gomez MA, et al. Presence of human papillomavirus in extrahepatic biliary atresia. J Pediatr Gastroenterol Nutr 1998; 27: 530–5. 10.1097/00005176-199811000-00007 CASPubMedWeb of Science®Google Scholar 51Drut R, Gomez MA, Drut RM, et al. [Human papillomavirus, neonatal giant cell hepatitis and biliary duct atresia]. Acta Gastroenterol Latinoam 1998; 28: 27–31. CASPubMedGoogle Scholar 52Domiati-Saad R, Dawson DB, Margraf LR, et al. Cytomegalovirus and human herpesvirus 6, but not human papillomavirus, are present in neonatal giant cell hepatitis and extrahepatic biliary atresia. Pediatr Dev Pathol 2000; 3: 367–73. 10.1007/s100240010045 CASPubMedWeb of Science®Google Scholar 53Mason AL, Xu L, Guo L, et al. Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders. Lancet 1998; 351: 1620–4. 10.1016/S0140-6736(97)10290-2 CASPubMedWeb of Science®Google Scholar 54Mason A, Nair S. Primary biliary cirrhosis: new thoughts on pathophysiology and treatment. Curr Gastroenterol Rep 2002; 4: 45–51. 10.1007/s11894-002-0037-8 PubMedGoogle Scholar 55Schreiber RA, Kleinman RE. Genetics, immunology, and biliary atresia: an opening or a diversion? J Pediatr Gastroenterol Nutr 1993; 16: 111–3. 10.1002/j.1536-4801.1993.tb10818.x CASPubMedWeb of Science®Google Scholar 56Burch J, Sokol RJ, Narkewicz MR, et al. The role of maternal antibodies in cholestatic liver disease in infants: a new isolated finding in neonatal lupus? J Pediatr Gastroenterol Nutr 2000; 31(suppl 2: S108. Google Scholar 57Donaldson PT, Manns MP. Immunogenetics of liver disease. In: J-P Benhamou, N McIntyre, M Rizetto, et al. eds. Oxford Textbook of Clinical Hepatology, 2nd ed. Oxford, New York: Oxford University Press; 1999: 173–88. Google Scholar 58Silveira TR, Salzano FM, Donaldson PT, et al. Association between HLA and extrahepatic biliary atresia. J Pediatr Gastroenterol Nutr 1993; 16: 114–7. 10.1002/j.1536-4801.1993.tb10819.x CASPubMedWeb of Science®Google Scholar 59Broome U, Nemeth A, Hultcrantz R, et al. Different expression of HLA-DR and ICAM-1 in livers from patients with biliary atresia and Byler's disease. J Hepatol 1997; 26: 857–62. 10.1016/S0168-8278(97)80253-X CASPubMedWeb of Science®Google Scholar 60Kobayashi H, Puri P, O'Briain DS, et al. Hepatic overexpression of MHC class II antigens and macrophage-associated antigens (CD68) in patients with biliary atresia of poor prognosis. J Pediatr Surg 1997; 32: 590–3. 10.1016/S0022-3468(97)90714-4 CASPubMedWeb of Science®Google Scholar 61Jurado A, Jara P, Camarena C, et al. Is extrahepatic biliary atresia an HLA-associated disease? J Pediatr Gastroenterol Nutr 1997; 25: 557–8. 10.1097/00005176-199711000-00015 CASPubMedWeb of Science®Google Scholar 62Donaldson PT, Clare M, Constantini PK, et al. HLA and cytokine gene polymorphisms in biliary atresia. Liver 2002; 22: 213–9. 10.1046/j.0106-9543.2002.01647.x CASPubMedWeb of Science®Google Scholar 63A Kader HH, El-Ayyouti M, Hawas S, et al. HLA in Egyptian children with biliary atresia. J Pediatr 2002; 141: 432–3. 10.1067/mpd.2002.127506 PubMedWeb of Science®Google Scholar 64Chapman RW. Role of immune factors in the pathogenesis of primary sclerosing cholangitis. Semin Liver Dis 1991; 11: 1–4. 10.1055/s-2008-1040415 CASPubMedWeb of Science®Google Scholar 65Gosseye S, Otte JB, De Meyer R, et al. A histological study of extrahepatic biliary atresia. Acta Paediatr Belg 1977; 30: 85–90. CASPubMedWeb of Science®Google Scholar 66Bill AH, Haas JE, Foster GL. Biliary atresia: histopathologic observations and reflections upon its natural history. J Pediatr Surg 1977; 12: 977–82. 10.1016/0022-3468(77)90609-1 CASPubMedWeb of Science®Google Scholar 67Ohya T, Fujimoto T, Shimomura H, et al. Degeneration of intrahepatic bile duct with lymphocyte infiltration into biliary epithelial cells in biliary atresia. J Pediatr Surg 1995; 30: 515–8. 10.1016/0022-3468(95)90120-5 CASPubMedWeb of Science®Google Scholar 68Abbas AK, Lichtman AH, Pober JS. Cellular and Molecular Immunology, 4th ed. Philadelphia: WB Saunders; 2000. Google Scholar 69Nakada M, Nakada K, Kawaguchi F, et al. Immunologic reaction and genetic factors in biliary atresia. Tohoku J Exp Med 1997; 181: 41–7. 10.1620/tjem.181.41 CASPubMedWeb of Science®Google Scholar 70Davenport M, Gonde C, Redkar R, et al. Immunohistochemistry of the liver and biliary tree in extrahepatic biliary atresia. J Pediatr Surg 2001; 36: 1017–25. 10.1053/jpsu.2001.24730 CASPubMedWeb of Science®Google Scholar 71Urushihara N, Iwagaki H, Yagi T, et al. Elevation of serum interleukin-18 levels and activation of Kupffer cells in biliary atresia. J Pediatr Surg 2000; 35: 446–9. 10.1016/S0022-3468(00)90211-2 CASPubMedWeb of Science®Google Scholar 72Funaki N, Sasano H, Shizawa S, et al. Apoptosis and cell proliferation in biliary atresia. J Pathol 1998; 186: 429–33. 10.1002/(SICI)1096-9896(199812)186:4 3.0.CO;2-6 CASPubMedWeb of Science®Google Scholar 73Liu C, Chiu JH, Chin T, et al. Expression of fas ligand on bile ductule epithelium in biliary atresia--a poor prognostic factor. J Pediatr Surg 2000; 35: 1591–6. 10.1053/jpsu.2000.18322 CASPubMedWeb of Science®Google Scholar 74Bezerra JA, Tiao G, Ryckman FC, et al. Genetic induction of proinflammatory immunity in children with biliary atresia. Lancet 2002; 360: 1653–9. 10.1016/S0140-6736(02)11603-5 PubMedWeb of Science®Google Scholar 75Vasiliauskas E, Targan S, Cobb L, et al. Biliary atresia--an autoimmune disorder? Hepatology 1995; 22(4 Pt 2: 87. Web of Science®Google Scholar 76Bernal W, Moloney M, Underhill J, et al. Association of tumor necrosis factor polymorphism with primary sclerosing cholangitis. J Hepatol 1999; 30: 237–41. 10.1016/S0168-8278(99)80068-3 CASPubMedWeb of Science®Google Scholar 77Mitchell SA, Grove J, Spurkland A, et al. Association of the tumour necrosis factor alpha-308 but not the interleukin 10-627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis. Gut 2001; 49: 288–94. 10.1136/gut.49.2.288 CASPubMedWeb of Science®Google Scholar 78Donaldson P, Agarwal K, Craggs A, et al. HLA and interleukin 1 gene polymorphisms in primary biliary cirrhosis: associations with disease progression and disease susceptibility. Gut 2001; 48: 397–402. 10.1136/gut.48.3.397 CASPubMedWeb of Science®Google Scholar 79Grove J, Daly AK, Bassendine MF, et al. Interleukin 10 promoter region polymorphisms and susceptibility to advanced alcoholic liver disease. Gut 2000; 46: 540–5. 10.1136/gut.46.4.540 CASPubMedWeb of Science®Google Scholar 80Yee LJ, Tang J, Gibson AW, et al. Interleukin 10 polymorphisms as predictors of sustained response in antiviral therapy for chronic hepatitis C infection. Hepatology 2001; 33: 708–12. 10.1053/jhep.2001.22347 CASPubMedWeb of Science®Google Scholar 81Klippel CH. A new theory of biliary atresia. J Pediatr Surg 1972; 7: 651–4. 10.1016/0022-3468(72)90274-6 CASPubMedWeb of Science®Google Scholar 82Pickett LK, Briggs HC. Biliary obstruction secondary to hepatic vascular ligation in fetal sheep. J Pediatr Surg 1969; 4: 95–101. 10.1016/0022-3468(69)90188-2 CASPubMedWeb of Science®Google Scholar 83Ho CW, Shioda K, Shirasaki K, et al. The pathogenesis of biliary atresia: a morphological study of the hepatobiliary system and the hepatic artery. J Pediatr Gastroenterol Nutr 1993; 16: 53–60. 10.1002/j.1536-4801.1993.tb10801.x CASPubMedWeb of Science®Google Scholar 84Yokoyama T, Copeland NG, Jenkins NA, et al. Reversal of left-right asymmetry: a situs inversus mutation. Science 1993; 260: 679–82. 10.1126/science.8480178 CASPubMedWeb of Science®Google Scholar 85Schon P, Tsuchiya K, Lenoir D, et al. Identification, genomic organization, chromosomal mapping and mutation analysis of the human INV gene, the ortholog of a murine gene implicated in left-right axis development and biliary atresia. Hum Genet 2002; 110: 157–65. 10.1007/s00439-001-0655-5 CASPubMedWeb of Science®Google Scholar 86Bamford RN, Roessler E, Burdine RD, et al. Loss-of-function mutations in the EGF-CFC gene CFC1 are associated with human left-right laterality defects. Nat Genet 2000; 26: 365–9. 10.1038/81695 CASPubMedWeb of Science®Google Scholar 87Jacquemin E, Cresteil D, Raynaud N, et al. CFCI gene mutation and biliary atresia with polysplenia syndrome. J Pediatr Gastroenterol Nutr 2002; 34: 326–7. 10.1002/j.1536-4801.2002.tb07616.x PubMedWeb of Science®Google Scholar 88Schmidt C, Bladt F, Goedecke S, et al. Scatter factor/hepatocyte growth factor is essential for liver development. Nature 1995; 373: 699–702. 10.1038/373699a0 CASPubMedWeb of Science®Google Scholar 89Kohsaka T, Yuan ZR, Guo SX, et al. The significance of human jagged 1 mutations detected in severe cases of extrahepatic biliary atresia. Hepatology 2002; 36: 904–12. 10.1053/jhep.2002.35820 CASPubMedWeb of Science®Google Scholar 90Clotman F, Lannoy VJ, Reber M, et al. The onecut transcription factor HNF6 is required for normal development of the biliary tract. Development 2002; 129: 1819–28. 10.1242/dev.129.8.1819 CASPubMedWeb of Science®Google Scholar 91Harper P, Plant JW, Unger DB. Congenital biliary atresia and jaundice in lambs and calves. Aust Vet J 1990; 67: 18–22. 10.1111/j.1751-0813.1990.tb07385.x CASPubMedWeb of Science®Google Scholar 92Balistreri WF, Bove K, Ryckman FC. Biliary atresia and other disorders of the extrahepatic bile ducts. In: FJ Suchy, RJ Sokol, WF Balistreri, eds. Liver Disease in Children. Philadelphia: Lippincott, Williams & Wilkins; 2001: 253–74. Google Scholar 93Zerbini MC, Gallucci SD, Maezono R, et al. Liver biopsy in neonatal cholestasis: a review on statistical grounds. Mod Pathol 1997; 10: 793–9. CASPubMedWeb of Science®Google Scholar 94Deutsch GH, Sokol RJ, Stathos TH, et al. Proliferation to paucity: evolution of bile duct abnormalities in a case of Alagille syndrome. Pediatr Dev Pathol 2001; 4: 559–63. 10.1007/s10024001-0102-6 CASPubMedWeb of Science®Google Scholar 95Gilmour SM, Hershkop M, Reifen R, et al. Outcome of hepatobiliary scanning in neonatal hepatitis syndrome. J Nucl Med 1997; 38: 1279–82. CASPubMedWeb of Science®Google Scholar 96Farrant P, Meire HB, Mieli-Vergani G. Improved diagnosis of extraheptic biliary atresia by high frequency ultrasound of the gall bladder. Br J Radiol 2001; 74: 952–4. 10.1259/bjr.74.886.740952 CASPubMedWeb of Science®Google Scholar 97Choi SO, Park WH, Lee HJ, et al. “Triangular cord:” a sonographic finding applicable in the diagnosis of biliary atresia. J Pediatr Surg 1996; 31: 363–6. 10.1016/S0022-3468(96)90739-3 CASPubMedWeb of Science®Google Scholar 98Guibaud L, Lachaud A, Touraine R, et al. MR cholangiography in neonates and infants: feasibility and preliminary applications. AJR Am J Roentgenol 1998; 170: 27–31. 10.2214/ajr.170.1.9423592 CASPubMedWeb of Science®Google Scholar 99Norton KI, Glass RB, Kogan D, et al. MR cholangiography in the evaluation of neonatal cholestasis: initial results. Radiology 2002; 222: 687–91. 10.1148/radiol.2223010969 PubMedWeb of Science®Google Scholar 100Wilkinson ML, Mieli-Vergani G, Ball C, et al. Endoscopic retrograde cholangiopancreatography in infantile cholestasis. Arch Dis Child 1991; 66: 121–3. 10.1136/adc.66.1.121 CASPubMedWeb of Science®Google Scholar 101Iinuma Y, Narisawa R, Iwafuchi M, et al. The role of endoscopic retrograde cholangiopancreatography in infants with cholestasis. J Pediatr Surg 2000; 35: 545–9. 10.1053/jpsu.2000.0350545 CASPubMedWeb of Science®Google Scholar 102Meisheri IV, Kasat LS, Kumar A, et al. Duodenal intubation and test for bile--a reliable method to rule out biliary atresia. Pediatr Surg Int 2002; 18: 392–5. 10.1007/s00383-002-0767-6 CASPubMedWeb of Science®Google Scholar 103Larrosa-Haro A, Caro-Lopez AM, Coello-Ramirez P, et al. Duodenal tube test in the diagnosis of biliary atresia. J Pediatr Gastroenterol Nutr 2001; 32: 311–5. 10.1002/j.1536-4801.2001.tb07274.x CASPubMedWeb of Science®Google Scholar 104Matsui A, Dodoriki M. Screening for biliary atresia. Lancet 1995; 345: 1181. 10.1016/S0140-6736(95)91013-1 CASPubMedWeb of Science®Google Scholar 105Garel LA, Belli D, Grignon A, et al. Percutaneous cholecystography in children. Radiology 1987; 165: 639–41. 10.1148/radiology.165.3.3685343 CASPubMedWeb of Science®Google Scholar 106Markowitz J, Daum F, Kahn EI, et al. Arteriohepatic dysplasia. I. Pitfalls in diagnosis and management. Hepatology 1983; 3: 74–6. 10.1002/hep.1840030112 CASPubMedWeb of Science®Google Scholar 107Karrer FM, Bensard DD. Neonatal cholestasis. Semin Pediatr Surg 2000; 9: 166–9. 10.1053/spsu.2000.18847 CASPubMedGoogle Scholar 108Chardot C, Carton M, Spire-Bendelac N, et al. Epidemiology of biliary atresia in France: a national study 1986-96. J Hepatol 1999; 31: 1006–13. 10.1016/S0168-8278(99)80312-2 CASPubMedWeb of Science®Google Scholar 109Chardot C, Carton M, Spire-Bendelac N, et al. Is the Kasai operation still indicated in children older than 3 months diagnosed with biliary atresia? J Pediatr 2001; 138: 224–8. 10.1067/mpd.2001.111276 CASPubMedWeb of Science®Google Scholar 110Mones RL, DeFelice AR, Preud'Homme D. Use of neomycin as the prophylaxis against recurrent cholangitis after Kasai portoenterostomy. J Pediatr Surg 1994; 29: 422–4. 10.1016/0022-3468(94)90583-5 CASPubMedWeb of Science®Google Scholar 111Karrer FM, Lilly JR. Corticosteroid therapy in biliary atresia. J Pediatr Surg 1985; 20: 693–5. 10.1016/S0022-3468(85)80026-9 CASPubMedWeb of Science®Google Scholar 112Balistreri WF. Bile acid therapy in pediatric hepatobiliary disease: the role of ursodeoxycholic acid. J Pediatr Gastroenterol Nutr 1997; 24: 573–89. 10.1097/00005176-199705000-00016 CASPubMedWeb of Science®Google Scholar 113Chin SE, Shepherd RW, Cleghorn GJ, et al. Pre-operative nutritional support in children with end-stage liver disease accepted for liver transplantation: an approach to management. J Gastroenterol Hepatol 1990; 5: 566–72. 10.1111/j.1440-1746.1990.tb01442.x CASPubMedWeb of Science®Google Scholar 114Lilly JR. Experimental investigations into the etiology of cholangitis following operation for biliary atresia. J Pediatr Surg 1978; 13: 559–60. 10.1016/S0022-3468(78)80384-4 CASPubMedWeb of Science®Google Scholar 115Muraji T, Higashimoto Y. The improved outlook for biliary atresia with corticosteroid therapy. J Pediatr Surg 1997; 32: 1103–6; discussion 1106-7. 10.1016/S0022-3468(97)90408-5 CASPubMedWeb of Science®Google Scholar 116Dillon PW, Owings E, Cilley R, et al. Immunosuppression as adjuvant therapy for biliary atresia. J Pediatr Surg 2001; 36: 80–5. 10.1053/jpsu.2001.20013 CASPubMedWeb of Science®Google Scholar 117van Rossum TG, Vulto AG, Hop WC, et al. Glycyrrhizin-induced reduction of ALT in European patients with chronic hepatitis C. Am J Gastroenterol 2001; 96: 2432–7. 10.1016/S0002-9270(01)02612-0 PubMedWeb of Science®Google Scholar 118Vohra P, Haller C, Emre S, et al. Neonatal hemochromatosis: the importance of early recognition of liver failure. J Pediatr 2000; 136: 537–41. 10.1016/S0022-3476(00)90020-9 CASPubMedWeb of Science®Google Scholar 119Melter M, Rodeck B, Kardorff R, et al. Progressive familial intrahepatic cholestasis: partial biliary diversion normalizes serum lipids and improves growth in noncirrhotic patients. Am J Gastroenterol 2000; 95: 3522–8. 10.1111/j.1572-0241.2000.03370.x CASPubMedWeb of Science®Google Scholar 120Ng VL, Ryckman FC, Porta G, et al. Long-term outcome after partial external biliary diversion for intractable pruritus in patients with intrahepatic cholestasis. J Pediatr Gastroenterol Nutr 2000; 30: 152–6. 10.1097/00005176-200002000-00011 CASPubMedWeb of Science®Google Scholar 121Emerick KM, Whitington PF. Partial external biliary diversion for intractable pruritus and xanthomas in Alagille syndrome. Hepatology 2002; 35: 1501–6. 10.1053/jhep.2002.33332 PubMedWeb of Science®Google Scholar 122Karrer FM, Price MR, Bensard DD, et al. Long-term results with the Kasai operation for biliary atresia. Arch Surg 1996; 131: 493–6. 10.1001/archsurg.1996.01430170039006 CASPubMedWeb of Science®Google Scholar 123Laurent J, Gauthier F, Bernard O, et al. Long-term outcome after surgery for biliary atresia. Study of 40 patients surviving for more than 10 years. Gastroenterology 1990; 99: 1793–7. 10.1016/0016-5085(90)90489-N CASPubMedWeb of Science®Google Scholar 124Howard ER, MacLean G, Nio M, et al. Survival patterns in biliary atresia and comparison of quality of life of long-term survivors in Japan and England. J Pediatr Surg 2001; 36: 892–7. 10.1053/jpsu.2001.23965 CASPubMedWeb of Science®Google Scholar 125McKiernan PJ, Baker AJ, Kelly DA. The frequency and outcome of biliary atresia in the UK and Ireland. Lancet 2000; 355: 25–9. 10.1016/S0140-6736(99)03492-3 CASPubMedWeb of Science®Google Scholar 126Stewart SM, Uauy R, Kennard BD, et al. Mental development and growth in children with chronic liver disease of early and late onset. Pediatrics 1988; 82: 167–72. CASPubMedWeb of Science®Google Scholar 127Stewart SM, Uauy R, Waller DA, et al. Mental and motor development, social competence, and growth one year after successful pediatric liver transplantation. J Pediatr 1989; 114(4 Pt 1): 574–81. 10.1016/S0022-3476(89)80696-1 CASPubMedWeb of Science®Google Scholar 128Wayman KI, Cox KL, Esquivel CO. Neurodevelopmental outcome of young children with extrahepatic biliary atresia 1 year after liver transplantation. J Pediatr 1997; 131: 894–8. 10.1016/S0022-3476(97)70039-8 CASPubMedWeb of Science®Google Scholar 129Miga D, Sokol RJ, Mackenzie T, et al. Survival after first esophageal variceal hemorrhage in patients with biliary atresia. J Pediatr 2001; 139: 291–6. 10.1067/mpd.2001.115967 CASPubMedWeb of Science®Google Scholar 130Goncalves ME, Cardoso SR, Maksoud JG. Prophylactic sclerotherapy in children with esophageal varices: long-term results of a controlled prospective randomized trial. J Pediatr Surg 2000; 35: 401–5. 10.1016/S0022-3468(00)90203-3 CASPubMedWeb of Science®Google Scholar 131Lui HF, Stanley AJ, Forrest EH, et al. Primary prophylaxis of variceal hemorrhage: a randomized controlled trial comparing band ligation, propranolol, and isosorbide mononitrate. Gastroenterology 2002; 123: 735–44. 10.1053/gast.2002.35385 CASPubMedWeb of Science®Google Scholar 132Ozsoylu S, Kocak N, Demir H, et al. Propranolol for primary and secondary prophylaxis of variceal bleeding in children with cirrhosis. Turk J Pediatr 2000; 42: 31–3. CASPubMedWeb of Science®Google Scholar 133Shashidhar H, Langhans N, Grand RJ. Propranolol in prevention of portal hypertensive hemorrhage in children: a pilot study. J Pediatr Gastroenterol Nutr 1999; 29: 12–7. 10.1097/00005176-199907000-00007 CASPubMedWeb of Science®Google Scholar 134Karrer FM, Narkewicz MR. Esophageal varices: current management in children. Semin Pediatr Surg 1999; 8: 193–201. 10.1016/S1055-8586(99)70026-0 CASPubMedGoogle Scholar 135Sasaki T, Hasegawa T, Nakajima K, et al. Endoscopic variceal ligation in the management of gastroesophageal varices in postoperative biliary atresia. J Pediatr Surg 1998; 33: 1628–32. 10.1016/S0022-3468(98)90595-4 CASPubMedWeb of Science®Google Scholar 136McKiernan PJ, Beath SV, Davison SM. A prospective study of endoscopic esophageal variceal ligation using a multiband ligator. J Pediatr Gastroenterol Nutr 2002; 34: 207–11. 10.1002/j.1536-4801.2002.tb07602.x PubMedWeb of Science®Google Scholar 137Price MR, Sartorelli KH, Karrer FM, et al. Management of esophageal varices in children by endoscopic variceal ligation. J Pediatr Surg 1996; 31: 1056–9. 10.1016/S0022-3468(96)90086-X CASPubMedWeb of Science®Google Scholar 138Hackworth CA, Leef JA, Rosenblum JD, et al. Transjugular intrahepatic portosystemic shunt creation in children: initial clinical experience. Radiology 1998; 206: 109–14. 10.1148/radiology.206.1.9423659 CASPubMedWeb of Science®Google Scholar 139Heyman MB, LaBerge JM, Somberg KA, et al. Transjugular intrahepatic portosystemic shunts (TIPS) in children. J Pediatr 1997; 131: 914–9. 10.1016/S0022-3476(97)70043-X CASPubMedWeb of Science®Google Scholar 140Brandt CT, Rothbarth LJ, Kumpe D, et al. Splenic embolization in children: long-term efficacy. J Pediatr Surg 1989; 24: 642–4; discussion 644-5. 10.1016/S0022-3468(89)80710-9 CASPubMedWeb of Science®Google Scholar 141Harned RK 2nd, Thompson HR, Kumpe DA, et al. Partial splenic embolization in five children with hypersplenism: effects of reduced-volume embolization on efficacy and morbidity. Radiology 1998; 209: 803–6. 10.1148/radiology.209.3.9844678 PubMedWeb of Science®Google Scholar 142Trivedi P, Dhawan A, Risteli J, et al. Prognostic value of serum hyaluronic acid and type I and III procollagen propeptides in extrahepatic biliary atresia. Pediatr Res 1995; 38: 568–73. 10.1203/00006450-199510000-00016 CASPubMedWeb of Science®Google Scholar 143Kobayashi H, Miyano T, Horikoshi K, et al. Prognostic value of serum procollagen III peptide and type IV collagen in patients with biliary atresia. J Pediatr Surg 1998; 33: 112–4. 10.1016/S0022-3468(98)90374-8 CASPubMedWeb of Science®Google Scholar 144Broide E, Farrant P, Reid F, et al. Hepatic artery resistance index can predict early death in children with biliary atresia. Liver Transpl Surg 1997; 3: 604–10. 10.1002/lt.500030609 CASPubMedGoogle Scholar 145Fujimoto T, Ohya T, Miyano T. A new clinical prognostic predictor for patients with biliary atresia. J Pediatr Surg 1994; 29: 757–60. 10.1016/0022-3468(94)90363-8 CASPubMedWeb of Science®Google Scholar 146Vazquez-Estevez J, Stewart B, Shikes RH, et al. Biliary atresia: early determination of prognosis. J Pediatr Surg 1989; 24: 48–50; discussion 50-1. 10.1016/S0022-3468(89)80300-8 CASPubMedWeb of Science®Google Scholar 147Endo M, Masuyama H, Watanabe K, et al. Calculation of biliary atresia prognostic index using a multivariate linear model. J Pediatr Surg 1995; 30: 1575–9. 10.1016/0022-3468(95)90160-4 CASPubMedWeb of Science®Google Scholar 148Malatack JJ, Schaid DJ, Urbach AH, et al. Choosing a pediatric recipient for orthotopic liver transplantation. J Pediatr 1987; 111: 479–89. 10.1016/S0022-3476(87)80105-1 CASPubMedWeb of Science®Google Scholar 149McDiarmid SV, Anand R, Lindblad AS. Development of a pediatric end-stage liver disease score to predict poor outcome in children awaiting liver transplantation. Transplantation 2002; 74: 173–81. 10.1097/00007890-200207270-00006 PubMedWeb of Science®Google Scholar 150Schweizer P, Lunzmann K. Extrahepatic bile duct atresia: how efficient is the hepatoporto-enterostomy? Eur J Pediatr Surg 1998; 8: 150–4. 10.1055/s-2008-1071143 CASPubMedWeb of Science®Google Scholar 151Mowat AP, Davidson LL, Dick MC. Earlier identification of biliary atresia and hepatobiliary disease: selective screening in the third week of life. Arch Dis Child 1995; 72: 90–2. 10.1136/adc.72.1.90 CASPubMedWeb of Science®Google Scholar 152 2000 Annual Report. The US Scientific Registry of Transplant Recipients and The Organ Procurement and Transplantation Network. HHS/HRS/OSP/DOT;United Network for Organ Sharing, pp. 191–236. Google Scholar Citing Literature Volume37, Issue1July 2003Pages 4-21 ReferencesRelatedInformation